Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Therapeutic Effects of Botulinum Toxin Type A and Triamcinolone Injection in Managing Facial Myalgia: A Single Blind Randomized Controlled Trial

NCT07867379 is registered in ClinicalTrials.gov with Riyadh Elm University as lead sponsor.

NCT NCT07867379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07867379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Therapeutic Effects of Botulinum Toxin Type A and Triamcinolone Injection in Managing Facial Myalgia: A Single Blind Randomized Controlled Trial
Lead sponsor
Riyadh Elm University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 11, 2026
Completion date
December 24, 2026
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myofascial pain syndrome (mps)